Back to trial
Severity is deterministic uncalibrated triage metadata, not validated review priority. Operation-level severity
is inferred from deterministic path rules. Rule matches shown per operation are approximate previews (they skip
the pipeline's suppression passes); the authoritative classification is the stored
event record.
Plain-language summary
Manual review pending.
Rules fired
contact_admin_change
Value signals
[
{
"path": "/protocolSection/statusModule/primaryCompletionDateStruct/date",
"signal": "timeline_actualized_earlier",
"category": "timeline_actualized_earlier",
"new_type": "ACTUAL",
"old_type": "ESTIMATED",
"severity": "low",
"direction": "earlier",
"new_value": "2024-10-08",
"old_value": "2026-08-08",
"delta_days": 669,
"date_struct": "primaryCompletionDateStruct",
"new_precision": "day",
"old_precision": "day"
}
] Provenance
Source ctgov_internal_history
Fetched 2026-06-18 18:58:42+00
Raw hash 6b035df798d51b22ba5fb4c511538697322b55c3fe2f00340feafd3a07ee97d1 Timeline Start, primary completion, and completion date movement. Triage: Medium 2 ops replace /protocolSection/statusModule/primaryCompletionDateStruct/date
Triage: Medium Timeline Shift Operation 5
Matched rules primary_completion_timeline_change Primary completion date changes are operational timeline signals. replace /protocolSection/statusModule/primaryCompletionDateStruct/type
Triage: Medium Timeline Shift Operation 6
Matched rules primary_completion_timeline_change Primary completion date changes are operational timeline signals. Contacts and locations Site, contact, and location updates that are usually operational. Triage: Low 3 ops remove /protocolSection/contactsLocationsModule/centralContacts
Triage: Low Administrative Contact Change Operation 10
Matched rules contact_admin_change Central contact updates are usually administrative. Before
[
{
"name": "Amy Oppenheim",
"role": "CONTACT",
"email": "Amy.Oppenheim@cshs.org",
"phone": "310-423-3713"
}
] remove /protocolSection/contactsLocationsModule/locations/0/status
Triage: Uncategorized Uncategorized Operation 11
remove /protocolSection/contactsLocationsModule/locations/0/contacts
Triage: Uncategorized Uncategorized Operation 12
Before
[
{
"name": "Amy Oppenheim",
"role": "CONTACT",
"email": "Amy.Oppenheim@cshs.org",
"phone": "310-423-3713"
},
{
"name": "Philomena McAndrew, MD",
"role": "SUB_INVESTIGATOR"
},
{
"name": "Dorothy Park, MD",
"role": "SUB_INVESTIGATOR"
},
{
"name": "Maryliza El-Masry, MD",
"role": "SUB_INVESTIGATOR"
},
{
"name": "Yuan Yuan, MD",
"role": "PRINCIPAL_INVESTIGATOR"
}
] Other registry fields Changes outside the current high-signal rule families. Triage: Uncategorized 3 ops replace /protocolSection/statusModule/statusVerifiedDate
Triage: Uncategorized Uncategorized Operation 3
replace /protocolSection/statusModule/lastUpdateSubmitDate
Triage: Uncategorized Uncategorized Operation 7
replace /protocolSection/statusModule/lastUpdatePostDateStruct/date
Triage: Uncategorized Uncategorized Operation 8
Sponsor and administrative fields Sponsor, collaborator, oversight, or registry maintenance changes. Triage: Uncategorized 3 ops replace /protocolSection/identificationModule/briefTitle
Triage: Uncategorized Uncategorized Operation 1
Before
Pembrolizumab in Combination With Olaparib in Advanced BRCA-mutated or HDR-defect Breast Cancer After
Pembrolizumab in Combination with Olaparib in Advanced BRCA-mutated or HDR-defect Breast Cancer replace /protocolSection/identificationModule/officialTitle
Triage: Uncategorized Uncategorized Operation 2
Before
Open Label, Phase II Pilot Study of Immune Checkpoint Inhibition With Pembrolizumab in Combination With PARP Inhibition With Olaparib in Advanced BRCA-mutated or HDR-defect Breast Cancers After
Open Label, Phase II Pilot Study of Immune Checkpoint Inhibition with Pembrolizumab in Combination with PARP Inhibition with Olaparib in Advanced BRCA-mutated or HDR-defect Breast Cancers add /protocolSection/oversightModule/isUsExport
Triage: Uncategorized Uncategorized Operation 9
Status and stopping reason Recruitment status, termination, suspension, withdrawal, or why-stopped text. Triage: Uncategorized 1 ops replace /protocolSection/statusModule/overallStatus
Triage: Uncategorized Uncategorized Operation 4
After
ACTIVE_NOT_RECRUITING Raw JSON Patch [
{
"op": "replace",
"path": "/protocolSection/identificationModule/briefTitle",
"value": "Pembrolizumab in Combination with Olaparib in Advanced BRCA-mutated or HDR-defect Breast Cancer"
},
{
"op": "replace",
"path": "/protocolSection/identificationModule/officialTitle",
"value": "Open Label, Phase II Pilot Study of Immune Checkpoint Inhibition with Pembrolizumab in Combination with PARP Inhibition with Olaparib in Advanced BRCA-mutated or HDR-defect Breast Cancers"
},
{
"op": "replace",
"path": "/protocolSection/statusModule/statusVerifiedDate",
"value": "2024-12"
},
{
"op": "replace",
"path": "/protocolSection/statusModule/overallStatus",
"value": "ACTIVE_NOT_RECRUITING"
},
{
"op": "replace",
"path": "/protocolSection/statusModule/primaryCompletionDateStruct/date",
"value": "2024-10-08"
},
{
"op": "replace",
"path": "/protocolSection/statusModule/primaryCompletionDateStruct/type",
"value": "ACTUAL"
},
{
"op": "replace",
"path": "/protocolSection/statusModule/lastUpdateSubmitDate",
"value": "2024-12-06"
},
{
"op": "replace",
"path": "/protocolSection/statusModule/lastUpdatePostDateStruct/date",
"value": "2024-12-11"
},
{
"op": "add",
"path": "/protocolSection/oversightModule/isUsExport",
"value": false
},
{
"op": "remove",
"path": "/protocolSection/contactsLocationsModule/centralContacts"
},
{
"op": "remove",
"path": "/protocolSection/contactsLocationsModule/locations/0/status"
},
{
"op": "remove",
"path": "/protocolSection/contactsLocationsModule/locations/0/contacts"
}
]